Deficient EBV-specific B- and T-cell response in patients with Chronic Fatigue Syndrome

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Loebel, Madlen ^a   Strohschein, Kristin ^a   Giannini, Carolin ^a   Koelsch, Uwe ^a   Bauer, Sandra ^a   Doebis, Cornelia ^b   Thomas, Sybill ^a   Unterwalder, Nadine ^a   Von Baehr, Volker ^b   Reinke, Petra ^a   Knops, Michael ^a   Hanitsch, Leif G ^a   Meisel, Christian ^a   Volk, Hans Dieter ^a   Scheibenbogen, Carmen ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Institute for Medical Diagnostics   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN; GAMMA INTERFERON; IMMEDIATE EARLY PROTEIN BZLF1; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA; VIRUS CAPSID ANTIGEN; PRIMER DNA; VIRUS ANTIBODY;

ADULT; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHRONIC FATIGUE SYNDROME; CONTROLLED STUDY; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS SPECIFIC B LYMPHOCYTE; EPSTEIN BARR VIRUS SPECIFIC T LYMPHOCYTE; EX VIVO STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MEMORY CELL; NONHUMAN; PROTEIN SECRETION; SECRETORY CELL; T LYMPHOCYTE; VIRUS LOAD; VIRUS REACTIVATION; VIRUS REPLICATION; AGED; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; T LYMPHOCYTE SUBPOPULATION; VIROLOGY;

ADULT; AGED; ANTIBODIES, VIRAL; B-LYMPHOCYTES; BASE SEQUENCE; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FATIGUE SYNDROME, CHRONIC; FEMALE; FLOW CYTOMETRY; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOLOGIC MEMORY; MALE; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES; VIRUS REPLICATION;

EID: 84898603621     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0085387     Document Type: Article

References (86)

1. Carruthers BM, Van De Sande MI, De Meirleir KL, Klimas NG, Broderick G, et al. (2011) Myalgic Encephalomyelitis: International Consensus Criteria. J Intern Med 270:327-338.
2. Christley Y, Duffy T, Martin CR (2012) A review of the definitional criteria for chronic fatigue syndrome. J Eval Clin Pract 18:25-31.
3. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, et al. (1994) The chronic fatigue syndrome: a comprehensive approach to its definition and st (Pubitemid 24370860)
4. Tanaka Y (2012) Biomarkers of stress and fatigue. Nihon Rinsho 70:880-886.
5. Bansal AS, Bradley AS, Bishop KN, Kiani-Alikhan S, Ford B (2012) Chronic fatigue syndrome, the immune system and viral infection. Brain Behav Immun 26:24-31.
6. Shepherd C (2002) Editorial on CFS was biased, inaccurate, and misleading. BMJ 324:914. (Pubitemid 34303951)
7. Jason LA, Torres-Harding SR, Carrico AW, Taylor RR (2002) Symptom occurrence in persons with chronic fatigue syndrome. Biol Psychol 59:15-27. (Pubitemid 34084798)
8. Maher KJ, Klimas NG, Fletcher MA (2005) Chronic fatigue syndrome is associated with diminished intracellular perforin. Clin Exp Immunol 142:505-511. (Pubitemid 41719847)
9. Jason LA, Fricano G, Taylor RR, Halpert J, Fennell PA, et al. (2000) Chronic fatigue syndrome: an examination of the phases. J Clin Psychol 56:1497-1508.
10. Brenu EW, Van Driel ML, Staines DR, Ashton KJ, Ramos SB, et al. (2011) Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis. J Transl Med 9:81.
11. Fletcher MA, Zeng XR, Maher K, Levis S, Hurwitz B, et al. (2010) Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV/CD26. PLoS One 5:e10817.
12. Skowera A, Cleare A, Blair D, Bevis L, Wessely SC, et al. (2004) High levels of type 2 cytokine-producing cells in chronic fatigue syndrome. Clin Exp Immunol 135:294-302. (Pubitemid 38177970)
13. Klimas NG, Salvato FR, Morgan R, Fletcher MA (1990) Immunologic abnormalities in chronic fatigue syndrome. J Clin Microbiol 28:1403-1410. (Pubitemid 20194439)
14. Straus SE, Fritz S, Dale JK, Gould B, Strober W (1993) Lymphocyte phenotype and function in the chronic fatigue syndrome. J Clin Immunol 13:30-40. (Pubitemid 23047994)
15. Curriu M, Carrillo J, Massanella M, Rigau J, Alegre J, et al. (2013) Screening NK-, B- and T-cell phenotype and function in patients suffering from Chronic Fatigue Syndrome. J Transl Med. doi: 10.1186/1479-5876-11-68.
16. Broderick G, Katz BZ, Fernandes H, Fletcher MA, Klimas N, et al. (2012) Cytokine expression profiles of immune imbalance in post-mononucleosis chronic fatigue. J Transl Med 10:191.
17. Broderick G, Fuite J, Kreitz A, Vernon SD, Klimas N, et al. (2010) A formal analysis of cytokine networks in chronic fatigue syndrome. Brain Behav Immun 24:1209-1217.
18. Lombardi VC, Ruscetti FW, Das Gupta J, Pfost MA, Hagen KS, et al. (2009) Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science 326:585-589.
19. Retraction in: Alberts B. (2011) Science 334:1636.
20. Partial retraction in: Silverman RH, Das Gupta J, Lombardi VC, Ruscetti FW, Pfost MA, et al. (2011) Science 334:176.
21. Hohn O, Strohschein K, Brandt AU, Seeher S, Klein S, et al. (2010) No evidence for XMRV in German CFS and MS patients with fatigue despite the ability of the virus to infect human blood cells in vitro. PLoS One 5:e15632.
22. Van Kuppeveld FJ, Van Der Meer JW (2012) XMRV and CFS-the sad end of a story. Lancet 379:e27-28.
23. Simmons G, Glynn SA, Komaroff AL, Mikovits JA, Tobler LH, et al. (2011) Failure to confirm XMRV/MLVs in the blood of patients with chronic fatigue syndrome: a multi-laboratory study. Science 334:814-817.
24. Komaroff AL, Cho TA (2011) Role of infection and neurologic dysfunction in chronic fatigue syndrome. Semin Neurol 31:325-337.
25. Schluederberg A, Straus SE, Peterson P, Blumenthal S, Komaroff AL, et al. (1992) NIH conference. Chronic fatigue syndrome research. Definition and medical outcome assessment. Ann Intern Med 117:325-331.
26. Josephs SF, Henry B, Balachandran N, Strayer D, Peterson D, et al. (1991) HHV-6 reactivation in chronic fatigue syndrome. Lancet 337:1346-1347.
27. Secchiero P, Zella D, Crowley RW, Gallo RC, Lusso P (1995) Quantitative PCR for human herpesviruses 6 and 7. J Clin Microbiol 33:2124-2130.
28. Patnaik M, Komaroff AL, Conley E, Ojo-Amaize EA, Peter JB (1995) Prevalence of IgM antibodies to human herpesvirus 6 early antigen (p41/38) in patients with chronic fatigue syndrome. J Infect Dis 172:1364-1367.
29. Ablashi DV, Eastman HB, Owen CB, Roman MM, Friedman J, et al. (2000) Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients. J Clin Virol 16:179-191. (Pubitemid 30157897)
30. Chapenko S, Krumina A, Logina I, Rasa S, Chistjakovs M, et al. (2012) Association of active human herpesvirus-6, -7 and parvovirus b19 infection with clinical outcomes in patients with myalgic encephalomyelitis/chronic fatigue syndrome. Adv Virol 2012:205085.
31. Chapenko S, Krumina A, Kozireva S, Nora Z, Sultanova A, et al. (2006) Activation of human herpesviruses 6 and 7 in patients with chronic fatigue syndrome. J Clin Virol 37 Suppl 1:S47-51.
32. Krueger GR, Koch B, Hoffmann A, Rojo J, Brandt ME, et al. (2001) Dynamics of chronic active herpesvirus-6 infection in patients with chronic fatigue syndrome: data acquisition for computer modeling. In Vivo 15:461-465. (Pubitemid 34187594)
33. Sairenji T, Yamanishi K, Tachibana Y, Bertoni G, Kurata T (1995) Antibody responses to Epstein-Barr virus, human herpesvirus 6 and human herpesvirus 7 in patients with chronic fatigue syndrome. Intervirology 38:269-273. (Pubitemid 26063983)
34. Burbelo PD, Bayat A, Wagner J, Nutman TB, Baraniuk JN, et al. (2012) No serological evidence for a role of HHV-6 infection in chronic fatigue syndrome. Am J Transl Res 4:443-451.
35. Frémont M, Metzger K, Rady H, Hulstaert J, De Meirleir K (2009) Detection of herpesviruses and parvovirus B19 in gastric and intestinal mucosa of chronic fatigue syndrome patients. In Vivo 23:209-213.
36. Beqaj SH, Lerner AM, Fitzgerald JT (2008) Immunoassay with cytomegalovirus early antigens from gene products p52 and CM2 (UL44 and UL57) detects active infection in patients with chronic fatigue syndrome. J Clin Pathol 61:623-626. (Pubitemid 351678216)
37. Lerner AM, Beqaj SH, Deeter RG, Fitzgerald JT (2002) IgM serum antibodies to human cytomegalovirus nonstructural gene products p52 and CM2 (UL44 and UL57) are uniquely present in a subset of patients with chronic fatigue syndrome. In Vivo 16:153-159.
38. Manian FA (1994) Simultaneous measurement of antibodies to Epstein-Barr virus, human herpesvirus 6, herpes simplex virus types 1 and 2, and 14 enteroviruses in chronic fatigue syndrome: is there evidence of activation of a nonspecific polyclonal immune response? Clin Infect Dis 19:448-453.
39. Cameron B, Flamand L, Juwana H, Middeldorp J, Naing Z, et al. (2010) Serological and virological investigation of the role of the herpesviruses EBV, CMV and HHV-6 in post-infective fatigue syndrome. J Med Virol 82:1684-1688.
40. Soto NE, Straus SE (2000) Chronic Fatigue Syndrome and Herpesviruses: the Fading Evidence. Herpes 7:46-50. (Pubitemid 30316097)
41. Lerner AM, Beqaj SH, Deeter RG, Fitzgerald JT (2004) IgM serum antibodies to Epstein-Barr virus are uniquely present in a subset of patients with the chronic fatigue syndrome. In Vivo 18:101-106. (Pubitemid 38488991)
42. Lerner AM, Ariza ME, Williams M, Jason L, Beqaj S, et al. (2012) Antibody to Epstein-Barr virus deoxyuridine triphosphate nucleotidohydrolase and deoxyribonucleotide polymerase in a chronic fatigue syndrome subset. PLoS One 7:e47891.
43. Kawai K, Kawai A (1992) Studies on the relationship between chronic fatigue syndrome and Epstein-Barr virus in Japan. Intern Med 31:313-318.
44. Wallace HL 2nd, Natelson B, Gause W, Hay J (1999) Human herpesviruses in chronic fatigue syndrome. Clin Diagn Lab Immunol 6:216-223. (Pubitemid 29124968)
45. Whelton CL, Salit I, Moldofsky H (1992) Sleep, Epstein-Barr virus infection, musculoskeletal pain, and depressive symptoms in chronic fatigue syndrome. J Rheumatol 19:939-943.
46. Greenspan JS, Greenspan D, Lennette ET, Abrams DI, Conant MA, et al. (1985) Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associated lesion. N Engl J Med 313:1564-1571. (Pubitemid 16177395)
47. Sixbey JW, Nedrud JG, Raab-Traub N, Hanes RA, Pagano JS (1984) Epstein-Barr virus replication in oropharyngeal epithelial cells. N Engl J Med 310:1225-1230. (Pubitemid 14140362)
48. Nilsson K, Klein G, Henle W, Henle G (1971) The establishment of lymphoblastoid lines from adult and fetal human lymphoid tissue and its dependence on EBV. Int J Cancer 8:443-450.
49. Yates J, Warren N, Reisman D, Sugden B (1984) A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. Proc Natl Acad Sci U S A 81:3806-3610.
50. Altmann M, Pich D, Ruiss R, Wang J, Sugden B, et al. (2006) Transcriptional activation by EBV nuclear antigen 1 is essential for the expression of EBV's transforming genes. Proc Natl Acad Sci U S A 103:14188-14193. (Pubitemid 44453001)
51. Babcock GJ, Decker LL, Volk M, Thorley-Lawson DA (1998) EBV persistence in memory B-cells in vivo. Immunity 9:395-404. (Pubitemid 28462760)
52. Cohen JI (1999) The biology of Epstein-Barr virus: lessons learned from the virus and the host. Curr Opin Immunol 11:365-370. (Pubitemid 29377901)
53. Rezk SA, Weiss LM (2007) Epstein-Barr virus-associated lymphoproliferative disorders. Hum Pathol 38:1293-1304. (Pubitemid 47247493)
54. Klein G, Klein E, Kashuba E (2010) Interaction of Epstein-Barr virus (EBV) with human B-lymphocytes. Biochem Biophys Res Commun 396:67-73.
55. Tsurumi T, Fujita M, Kudoh A (2005) Latent and lytic Epstein-Barr virus replication strategies. Rev Med Virol 15:3-15. (Pubitemid 40070039)
56. Iwakiri D, Takada K (2010) Role of EBERs in the pathogenesis of EBV infection. Adv Cancer Res 107:119-136.
57. Lerner MR, Andrews NC, Miller G, Steitz JA (1981) Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus. Proc Natl Acad Sci U S A 78:805-809. (Pubitemid 11159514)
58. Niller HH, Wolf H, Ay E, Minarovits J (2011) Epigenetic dysregulation of epstein-barr virus latency and development of autoimmune disease. Adv Exp Med Biol 711:82-102.
59. Van Baarle D, Nanlohy NM, Otto S, Plunkett FJ, Fletcher JM, et al. (2008) Progressive telomere shortening of Epstein-Barr virus-specific memory T-cells during HIV infection: contributor to exhaustion? J Infect Dis 198:1353-1357.
60. Piriou E, Van Dort K, Nanlohy NM, Van Oers MH, Miedema F, et al. (2005) Loss of EBNA-1-specific memory CD4+ and CD8+ T-cells in HIV-infected patients progressing to AIDS-related non-Hodgkin lymphoma. Blood 106:3166-3174. (Pubitemid 41565915)
61. Piriou ER, Van Dort K, Nanlohy NM, Van Oers MH, Miedema F, et al. (2005) Novel method for detection of virus-specific CD41+ T-cells indicates a decreased EBV-specific CD4+ T-cell response in untreated HIV-infected subjects. Eur J Immunol 35:796-805. (Pubitemid 40425535)
62. Ling PD, Vilchez RA, Keitel WA, Poston DG, Peng RS, et al. (2003) Epstein-Barr virus DNA loads in adult human immunodeficiency virus type 1-infected patients receiving highly active antiretroviral therapy. Clin Infect Dis 37:1244-1249. (Pubitemid 37372515)
63. Crotty S, Aubert RD, Glidewell J, Ahmed R (2004) Tracking human antigenspecific memory B-cells: a sensitive and generalized ELISPOT system. J Immunol Methods 286:111-122. (Pubitemid 38490401)
64. Guerreiro M, Na IK, Letsch A, Haase D, Bauer S, et al. (2010) Human peripheral blood and bone marrow Epstein-Barr virus-specific T-cell repertoire in latent infection reveals distinct memory T-cell subsets. Eur J Immunol 40:1566-1576.
65. Patarca R (2001) Cytokines and chronic fatigue syndrome. Ann N Y Acad Sci 933:185-200. (Pubitemid 32386034)
66. Glaser R, Padgett DA, Litsky ML, Baiocchi RA, Yang EV, et al. (2005) Stress-associated changes in the steady-state expression of latent Epstein-Barr virus: implications for chronic fatigue syndrome and cancer. Brain Behav Immun 19:91-103. (Pubitemid 40138643)
67. Devanur LD, Kerr JR (2006) Chronic fatigue syndrome. J Clin Virol 37:139-150. (Pubitemid 44548485)
68. Miller G, Grogan E, Fischer DK, Niederman JC, Schooley RT, et al. (1985) Antibody responses to two Epstein-Barr virus nuclear antigens defined by gene transfer. N Engl J Med 312:750-755. (Pubitemid 15104796)
69. Henle W, Henle G, Andersson J, Ernberg I, Klein G, et al. (1987) Antibody responses to Epstein-Barr virus-determined nuclear antigen (EBNA)-1 and EBNA-2 in acute and chronic Epstein-Barr virus infection. Proc Natl Acad Sci U S A 84:570-574. (Pubitemid 17006237)
70. Almeida JR, Price DA, Papagno L, Arkoub ZA, Sauce D, et al. (2007) Superior control of HIV-1 replication by CD8+ T-cells is reflected by their avidity, polyfunctionality, and clonal turnover. J Exp Med 204:2473-2485. (Pubitemid 47529331)
71. Betts MR, Exley B, Price DA, Bansal A, Camacho ZT, et al. (2005) Characterization of functional and phenotypic changes in anti-Gag vaccineinduced T-cell responses and their role in protection after HIV-1 infection. Proc Natl Acad Sci U S A 102:4512-4517. (Pubitemid 40397143)
72. Rodrigue-Gervais IG, Rigsby H, Jouan L, Sauvé D, Sékaly RP, et al. (2010) Dendritic cell inhibition is connected to exhaustion of CD8+ T-cell polyfunctionality during chronic hepatitis C virus infection. J Immunol 184:3134-3144.
73. Radziewicz H, Ibegbu CC, Fernandez ML, Workowski KA, Obideen K, et al. (2007) Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression. J Virol 81:2545-2553. (Pubitemid 46447020)
74. Klatt NR, Vinton CL, Lynch RM, Canary LA, Ho J, et al. (2011) SIV infection of rhesus macaques results in dysfunctional T- and B-cell responses to neo and recall Leishmania major vaccination. Blood 118:5803-5812.
75. Colmenares M, Constant SL, Kima PE, McMahon-Pratt D (2002) Leishmania pifanoi pathogenesis: selective lack of a local cutaneous response in the absence of circulating antibody. Infect Immun 70:6597-6605. (Pubitemid 35387887)
76. El-Far M, Halwani R, Said E, Trautmann L, Doroudchi M, et al. (2008) T-cell exhaustion in HIV infection. Curr HIV/AIDS Rep 5:13-19. (Pubitemid 351480776)
77. Niller HH, Wolf H, Minarovits J (2008) Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases. Autoimmunity 41:298-328. (Pubitemid 351593860)
78. Draborg AH, Jørgensen JM, Müller H, Nielsen CT, Jacobsen S, et al. (2012) Epstein-Barr virus early antigen diffuse (EBV-EA/D)-directed immunoglobulin A antibodies in systemic lupus erythematosus patients. Scand J Rheumatol 41:280-289.
79. Larsen M, Sauce D, Deback C, Arnaud L, Mathian A, et al. (2011) Exhausted cytotoxic control of Epstein-Barr virus in human lupus. PLoS Pathog; doi: 10.1371/journal.ppat.1002328.
80. McClain MT, Heinlen LD, Dennis GJ, Roebuck J, Harley JB, et al. (2005) Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry. Nat Med 11:85-89. (Pubitemid 40215842)
81. Dreyfus DH (2011) Autoimmune disease: A role for new anti-viral therapies? Autoimmun Rev 11:88-97.
82. Chang CM, Warren JL, Engels EA (2012) Chronic fatigue syndrome and subsequent risk of cancer among elderly US adults. Cancer 118:5929-5936.
83. Ortega-Hernandez OD, Shoenfeld Y (2009) Infection, vaccination, and autoantibodies in chronic fatigue syndrome, cause or coincidence? Ann N Y Acad Sci 1173:600-609.
84. Jilek S, Schluep M, Meylan P, Vingerhoets F, Guignard L, et al. (2008) Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis. Brain 131:1712-1721. (Pubitemid 351957461)
85. Gabibov AG, Belogurov AA Jr, Lomakin YA, Zakharova MY, Avakyan ME, et al. (2011) Combinatorial antibody library from multiple sclerosis patients reveals antibodies that cross-react with myelin basic protein and EBV antigen. FASEB J 25:4211-4221.
86. Lünemann JD, Jelcić I, Roberts S, Lutterotti A, Tackenberg B, et al. (2008) EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2. J Exp Med 205:1763-1773.